Pharmaceuticals

Search results

Total results: 1154.
Address: 
Pfizer Inc
235 East 42nd Street 150/39/18
10017 New York , New York
United States
Phone: +1 (212) 733-7034
New York US
Official name: 
Pfizer Incorporated
Registration country: 
United States

Listed on the New York Stock Exchange (NYSE) as PFE
Address: 
Main Office
85 Medinat Hayehudim St Pituach
46766 Herzliya , Central
Israel
Central IL
Registration country: 
Israel
Overview: 
XTL Biopharmaceuticals Ltd. is a biopharmaceutical company focused on the development, in-licensing, acquisition, and commercialization of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet medical needs. The Company is focused on developing therapeutics for the treatment of multiple myeloma (MM) and hepatitis C (HCV). XTL is publicly traded on the Tel Aviv Stock Exchange (TASE) and its ADRs are quoted Over-the-Counter on the Pink Sheets in the US (TASE: XTL, Pink Sheets: XTLBY).
Address: 
Main Office
7720 North Dobson Road
85256 Scottsdale , Arizona
United States
Arizona US
Registration country: 
United States
Overview: 
Medicis Pharmaceutical Corporation is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions. Medicis is dedicated to helping patients attain a healthy and youthful appearance and self-image. Since our inception in 1988, we have introduced more than 25 new products and formulations, making us a prolific source of new products in the specialties we serve. Today, we have leading branded prescription products in a number of dermatological and aesthetic categories. Medicis products have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and cosmetic elegance. Medicis provides award-winning support to our physician-customers as they care for their patients and build their practices. We do this through new product development, growth of existing brands, strategic acquisitions, and collaborative relationships. Our goal is to maintain a strong leadership position in customer focus, both in dermatology and aesthetics, and other specialty fields we may enter.
Address: 
Main Office
300 Barr Harbor Drive 7th Floor, Five Tower Bridge
19428-2998 West Conshohocken , Pennsylvania
United States
Phone: +1 (610) 278-1660
Pennsylvania US
Official name: 
BTG Public Limited Company
Registration country: 
United States
Overview: 
BTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products.
Founded: 
1991
Address: 
Main Office
5 Fleet Place
EC4M 7RD London , London
United Kingdom
Phone: +44 (20) 7575-0000
London GB
Official name: 
BTG International Limited
Registration #: 
02664412
Registration country: 
United Kingdom
Overview: 
BTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products.
Address: 
Main Office
91 Milton Park
OX14 4RY Abingdon , Oxfordshire
United Kingdom
Phone: +44 (1235) 443-300
Oxfordshire GB
Official name: 
Oxagen Limited
Registration #: 
03246469
Registration country: 
United Kingdom
Company type: 
Overview: 
Oxagen is a privately held biopharmaceutical company developing a pipeline of novel small molecule drugs to treat inflammatory and respiratory diseases. The company has created a portfolio of valuable drug targets centered on the highly attractive class of receptors, GPCRs. Through its heritage in human genetics, Oxagen has validated a number of GPCR targets, many of them novel, and is progressing the most promising as drug targets. The lead program, targeting a GPCR known as CRTH2 with a strong genetic association to asthma, has generated a number of promising candidate small molecules which are orally bioavailable and offer the potential to treat asthma and other respiratory and inflammatory conditions.
Founded: 
2007
Address: 
Main Office
951 Gateway Blvd
94080 San Francisco , California
United States
California US
Official name: 
IPierian Incorporated
Registration country: 
United States
Company type: 
A biopharmaceutical company using patient-derived induced pluripotent stem cells for drug discovery
Address: 
Abbott Laboratories
100 Abbott Park Road
60064-3500 Abbott Park , Illinois
United States
Illinois US
Abbott Laboratories
100 Abbott Park Road
60064-3500 Abbott Park , Illinois
United States
Illinois US
Abbott Laboratories
100 Abbott Park Road
60064-3500 Abbott Park , Illinois
United States
Phone: +1 (847) 937-6100
Illinois US
Registration country: 
United States

Listed on the New York Stock Exchange (NYSE) as ABT
Overview: 
Abbott Laboratories (Abbott) is engaged in discovery, development, manufacture, and sale of diversified line of healthcare products. The Company operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Pharmaceutical Products include a line of adult and pediatric pharmaceuticals manufactured, marketed, and sold. Its Diagnostic Products include a line of diagnostic systems and tests manufactured, marketed, and sold to blood banks, hospitals, commercial laboratories, clinics, physicians' offices, alternate-care testing sites and plasma protein therapeutic companies. The Company’s Nutritional Products include a line of pediatric and adult nutritional products manufactured, marketed, and sold worldwide. Its Vascular Products include a line of coronary, endovascular, and vessel closure devices for the treatment of vascular disease manufactured, marketed and sold worldwide.
Founded: 
Jan 2010
Registration country: 
Russia
Company type: 
Developer of the innovative class of drug substance (curaxins) for oncological and autoimmune treatment diseases

Pages